Amsterdam UMC

What Amsterdam UMC does

Amsterdam UMC is a Dutch university medical center formed in 2018 from the merger of the Academic Medical Center (AMC, affiliated with the University of Amsterdam) and VU University Medical Center (VUmc, affiliated with Vrije Universiteit Amsterdam). The organization operates two hospital campuses in Amsterdam — AMC at Meibergdreef 9 and VUmc at De Boelelaan 1117 — running 208 outpatient clinics at AMC and 84 at VUmc, plus the Emma Children's Hospital and dozens of named expertisecentra covering complex and rare conditions such as Alzheimercentrum Amsterdam, Pulmonale Hypertensie, MKA-chirurgie, Borstcentrum and Schisis. Its patient base is regional Amsterdam plus national and international referrals requiring tertiary, high-complex specialty care delivered under the Dutch healthcare insurance framework (zorgverzekeringswet).

The core technology stack centers on an Epic/MyChart-based patient portal (Mijn Dossier), Poliklinische Apotheek outpatient pharmacy services with a DNA medication pass, and a parallel AI/research infrastructure spanning computer vision (AI CADe for Barrett's esophagus co-developed with Cosmo Pharmaceuticals and TU Eindhoven), biosignal analytics (Apple Watch PPG/ECG atrial fibrillation detection — 4x higher yield in a 437-patient JACC trial), MRI imaging (PARADISE ex vivo mouse heart platform with NWO funding), and large real-world data registries (ACCESS-AD InRAD platform with 500+ Alzheimer's patients). Education is delivered through the Amsterdam UMC Academie, Amstel Academie, MVO Leerhuis, Amsterdam UMC Doctoral School and the VU/UvA Faculties of Medicine, supported by SkillsLabs simulation infrastructure and recognized training networks such as RONA.

The business model is a hybrid academic medical center revenue stack rather than a commercial product. Clinical care revenue is generated through regulated Dutch healthcare insurance tariffs for inpatient, outpatient and complex specialty services, supplemented by outpatient pharmacy dispensing. Education revenue comes from tuition, course fees and in-company customization. Research is funded competitively through NWO, KWF, NRO and EU programs, supplemented by industry R&D collaboration and licensing deals (Cosmo, Siemens Healthineers, Nestlé, Pulse Biosciences, Apple) and donations via the VUmc donor program. Go-to-market is referral-driven for patients, partnership-driven for research, and event- and training-driven for education, with consolidated purchasing (Dienst Strategische Inkoop) and shared infrastructure across both campuses producing operational scale economies.

Name

Amsterdam UMC

Legal name

Amsterdam UMC, locatie VUmc

Website

https://vumc.nl

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Amsterdam UMC is a Dutch university medical center formed from the 2018 merger of AMC and VUmc, delivering tertiary patient care, biomedical research and medical education across two Amsterdam campuses serving referred regional and national patients.

Ownership category

akta.pro rank

Product category

Academic Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), Medical and Diagnostic Laboratories (6215), General Medical and Surgical Hospitals (622110)

SIC

Services-Medical Laboratories (8071), Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Academic hospital care
• Tertiary medical services
• Biomedical research
• Medical education programs
• Clinical specialty centers

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Healthcare services revenue: Clinical care delivery funded through the Dutch healthcare system (zorgverzekeringswet / healthcare insurance framework), including hospital admissions, outpatient consultations, complex care and second opinions. Operations supported by Strategic Purchasing (Dienst Strategische Inkoop).
2. Outpatient pharmacy services: Poliklinische Apotheek at both AMC and VUmc locations providing dispensing, compounded preparations and clinical-pharmacy advice on discharge and after outpatient visits.
3. Education and training fees: Tuition and course fees for Amsterdam UMC Academie, Amstel Academie, Doctoral School, MVO Leerhuis and VU/UvA Faculty of Medicine programs; in-company/customized training delivered on site.
4. Research grants and subsidies: Competitive research funding from NWO (Open Technology Programme, Large Scale Research Infrastructure), NRO, EU programs (Erasmus+, H2020 successors), KWF, and industry-sponsored collaborations.
5. Donations and philanthropy: Donor-funded research (e.g., Alzheimercentrum auction proceeds, "Steun ons, word donateur" program) supporting disease-specific research programs.
6. Industry R&D collaboration and licensing: Co-development agreements with medtech/pharma partners (e.g., Cosmo Pharmaceuticals for GI Genius expansion) combining clinical expertise, data, and validation; partner leads industrialization and regulatory pathway.

Pricing tiers

Go-to-market motion4 records

Distribution channels8 records

Marketing channels12 records

Core offering

Amsterdam UMC is a Dutch university medical center formed from the 2018 merger of AMC and VUmc that delivers tertiary and high-complex specialty patient care, biomedical and translational research, and medical and academic education across two Amsterdam campuses (AMC in Zuidoost and VUmc in Zuid). It operates dozens of recognized expertisecentra (e.g., Alzheimercentrum, Pulmonale Hypertensie, Emma Children's Hospital), provides outpatient pharmacy services, runs the Mijn Dossier patient portal, and conducts clinical research including AI-driven diagnostics and disease-modifying therapy implementation.

Product overview

Amsterdam UMC operates a portfolio of integrated healthcare, research and education offerings rather than a single software product. At its core is the Mijn Dossier patient portal (built on Epic's MyChart platform) which gives patients digital access to their medical records and appointments, paired with the Poliklinische Apotheek (Outpatient Pharmacy) services across both AMC and VUmc locations and the Mijn DNA medicatiepas personalized DNA medication tool. Around this core, Amsterdam UMC runs numerous specialized expertise centers (notably Alzheimercentrum Amsterdam and the Pulmonale Hypertensie Expertisecentrum) and operates the Emma Kinderziekenhuis pediatric hospital and the MKA-chirurgie oral and maxillofacial surgery specialty. On the education side, the MVO Leerhuis trains medical specialists, while the Amstel Academie, Amsterdam UMC Academie and VUmc School of Medical Sciences (Faculteit der Geneeskunde VU) provide nursing, specialist, doctoral (Amsterdam UMC Doctoral School) and continuing professional education through named programs including COSTA (AIOS training), HTZ (Horizontaal Toezicht Zorg), MOZ (Medewerker Operatieve Zorg), Superb supervision, and the national O²PZ palliative care program, supported by the SkillsLabs infrastructure and the BKO intensive program for professors. AI/ML capabilities are embedded through research collaborations including the AI-based Barrett's esophagus CADe system (with Cosmo GI Genius), the ACCESS-AD Alzheimer's consortium, the PARADISE MRI-compatible ex vivo heart platform, and clinical studies on smartwatch AF detection and football-heading biomarker analysis.

Differentiator

Problem solved

Functional benefit

Brands

• Alzheimercentrum Amsterdam: Center offering care and treatment for memory complaints and dementia, providing same-day screening diagnostics and scientific research into Alzheimer's disease.
• Amsterdam UMC Expertisecentrum voor Pulmonale Hypertensie
• Amsterdam UMC Academie
• Amstel Academie
• MVO Leerhuis
• Amsterdam UMC Doctoral School
• Emma Kinderziekenhuis
• Faculteit der Geneeskunde VU
• Faculteit der Geneeskunde UvA

Products and services

• Mijn Dossier (Patient Portal) Online Epic/MyChart-based portal giving patients access to medical records, treatment plans, appointment booking, video consultations, digital check-in for outpatient visits and e-prescriptions across both AMC and VUmc locations.
• Poliklinische Apotheek (Outpatient Pharmacy) Hospital pharmacy service with locations at AMC and VUmc that prepares and dispenses medications, conducts laboratory research, provides medication advice and operates a medication locker for patients.
• Mijn DNA medicatiepas Personalized DNA-based medication pass offered through the Amsterdam UMC pharmacy to help patients receive medication guidance tailored to their genetic profile.
• Alzheimercentrum Amsterdam Expertise center providing one-day diagnostic screening, treatment and scientific research for patients with memory complaints and dementia, including Alzheimer's disease; participates in the ACCESS-AD consortium.
• Amsterdam UMC Expertisecentrum voor Pulmonale Hypertensie Recognized European expertise center for investigation and treatment of Pulmonary Hypertension, operating a specialized outpatient clinic (PH Kenniscentrum polikliniek) at Amsterdam UMC, locatie VUmc.
• Emma Kinderziekenhuis (Emma Children's Hospital) Pediatric hospital within Amsterdam UMC providing specialized pediatric care across multiple subspecialties (AGOGO, AECO, Audiologisch Centrum, Ademhalingsstoornissen, Algemene Kindergeneeskunde, CAHAL), with a dedicated kids information portal.
• Mondziekten, kaak- en aangezichtschirurgie (MKA-chirurgie) Specialty at Amsterdam UMC addressing conditions of the mouth (teeth, jaws) and facial region, including facial fractures and head-neck tumors, with outpatient clinics at both VUmc and AMC locations.
• Amsterdam UMC Academie Continuing education provider within Amsterdam UMC offering training trajectories, courses, e-learning and in-company training for healthcare professionals, researchers, teachers and healthcare managers; Cedeo-certified with a 9.8 historical client-satisfaction score.
• Amstel Academie Education institute of Amsterdam UMC that trains specialized nurses and medical support staff with focus on clinical reasoning, proactivity and teamwork, in close collaboration with practical trainers in hospitals.
• Faculteit der Geneeskunde VU (VUmc School of Medical Sciences) Medical faculty of Vrije Universiteit Amsterdam that trains doctors and top researchers, offering the first Dutch geneeskunde opleiding without a cum laude regulation in the master phase, with the BKO intensive for professors.
• Amsterdam UMC Doctoral School Leading partner for PhD candidates and supervisors providing personal and professional development for young researchers, interdisciplinary networking opportunities and access to state-of-the-art research facilities.
• MVO Leerhuis Institute that trains the next generation of medical specialists and advises/guides virtually all recognized medical specialist training programs, optimizing training quality with focus on safe training climate, supervision professionalization and vitality.
• COSTA (Complexe Situatie Training voor AIOS) Four-day training program for AIOS (doctors in training to become specialists) from year two onward focused on effective communication, collaboration and personal leadership in complex hospital situations, combining theoretical models with experiential learning using training actors.
• Horizontaal Toezicht Zorg (HTZ) opleiding Four-day training program developed by the HTZ platform and VUmc Academie on collaborative supervision between healthcare insurers and providers, using Team Based Learning with content experts and the national HTZ Control Framework.
• O²PZ (Onderwijs en Opleiden Palliatieve Zorg) Multi-year national program led by VUmc Academie to embed palliative care in curricula of medical education at all levels (MBO, HBO, WO) and deliver a high-quality national continuing education offering for all professional caregivers in palliative care.
• SkillsLabs Amstel Academie en VUmc Academie Skills labs at the VU medical faculty building managed by Amstel Academie and VUmc Academie providing hands-on training in IV insertion, intubation, bed care, suturing, casting, endoscopic surgery, resuscitation, ACLS and a Bucky radiology room.
• Superb supervision (PhD supervision training) Pilot training program for PhD supervisors developed by VU and VUmc researchers, giving them tools and skills to mentor PhD candidates responsibly and with integrity through personal development, feedback skills and practical research tools.

Quantifiable outcome

• 4x higher atrial fibrillation detection with Apple Watch vs standard care in 437-patient trial (21 vs 5 diagnoses)
• +5 more outcomes

Named customers15 records

Segments7 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability11 records

Feature7 records

Partnerships

29 partnerships are on record, tiered core, flagship and minor.

• Royal Dutch Football Association (KNCB)coreStrategic or Co-development Partner · 23 May 2026Joint research collaboration studying the neurological effects of football heading across 11 men's amateur matches and 300+ players; published findings in JAMA Neurology linking heading frequency/intensity to temporary increases in neural damage biomarkers.
• Hospice BardocoreStrategic or Co-development Partner · 31 March 2026Co-developer with Amsterdam UMC Academie and Hospice Kuria of the broadened Basiscursus Palliatieve Zorg for healthcare professionals caring for patients in the palliative phase.
• Hospice KuriacoreStrategic or Co-development Partner · 31 March 2026Co-developer with Amsterdam UMC Academie and Hospice Bardo of the broadened Basiscursus Palliatieve Zorg; co-delivers palliative-care training within the KWF-subsidized Scholing PZ program.
• Cosmo Pharmaceuticals N.V.flagshipStrategic or Co-development Partner · 5 March 2026Strategic R&D collaboration to develop and clinically validate an AI-based computer-aided detection system for early neoplasia in Barrett's esophagus. Builds on Cosmo's GI Genius platform beyond colorectal screening into upper GI indications. Parties will combine clinical expertise, imaging research and engineering to curate datasets, develop AI algorithms, and conduct structured clinical validation. Cosmo leads industrialization and the regulatory pathway with future submissions planned in Europe and the United States.
• Eindhoven University of TechnologycoreStrategic or Co-development Partner · 5 March 2026Co-development partner in the AI computer-aided detection project for early neoplasia in Barrett's esophagus alongside Cosmo Pharmaceuticals and Amsterdam UMC, providing engineering capabilities and contributing to AI algorithm development.
• Cardiologie Centra NederlandcoreStrategic or Co-development Partner · 22 January 2026Co-investigator on the 437-patient Apple Watch atrial fibrillation detection study (the Amsterdam UMC smartwatch arm vs traditional adhesive chest electrode monitoring control arm), with findings published in JACC.
• Leiden University Medical Center (LUMC)coreStrategic or Co-development Partner · 21 January 2026Partner in the PARADISE consortium developing an MRI-compatible platform for imaging fully functional ex vivo mouse hearts, jointly awarded an NWO Open Technology grant led by Dr. Bram Coolen at Amsterdam UMC.
• Wageningen University & Research (WUR)coreStrategic or Co-development Partner · 21 January 2026Partner in the PARADISE consortium (Amsterdam UMC, LUMC, WUR) developing MRI-compatible ex vivo mouse heart imaging, jointly awarded an NWO Open Technology grant.
• AMICE consortiumcoreStrategic or Co-development Partner · 21 January 2026Amsterdam UMC participates in the AMICE consortium that received a separate NWO Large Scale Research Infrastructure grant, collaborating to make the PARADISE ex vivo MRI platform available to researchers across the Netherlands.
• Siemens HealthineersflagshipStrategic or Co-development Partner · 13 January 2026Co-leads the five-year ACCESS-AD European initiative to accelerate Alzheimer's disease care innovations, address diagnostic bottlenecks, and support implementation of newly approved disease-modifying therapies (lecanemab and donanemab) through AI-driven tools, biomarkers and integrated care pathways.
• King's College LondonflagshipStrategic or Co-development Partner · 13 January 2026Co-leads the ACCESS-AD pan-European consortium with Amsterdam UMC, Siemens Healthineers and Gates Ventures, contributing clinical and research expertise to translate Alzheimer's disease-modifying therapies into European health-system practice.
• Gates VenturesflagshipStrategic or Co-development Partner · 13 January 2026Co-leads the ACCESS-AD consortium and supports the pan-European AD registry on the InRAD platform that will collect real-world data from over 500 patients to support disease-modifying therapy implementation.
• NestlécoreStrategic or Co-development Partner · 13 January 2026Industry partner within ACCESS-AD providing nutritional supplements for a pilot study combining disease-modifying Alzheimer's therapies with nutritional intervention.
• Erasmus MCcoreStrategic or Co-development Partner · 1 February 2019Joint research partner with Amsterdam UMC on selection-for-medicine and diversity research funded by a €275,000 NRO subsidy to Rashmi Kusurkar, Gerda Croiset and Anouk Wouters.
• University of Twente (Technical Medicine)coreStrategic or Co-development Partner · 1 February 2019Consortium partner in NRO-funded research into unintended effects of medical-school selection on student diversity, alongside Amsterdam UMC (VUmc and AMC), Erasmus MC and Universiteit Utrecht.
• Utrecht University (Pharmaceutical Sciences)coreStrategic or Co-development Partner · 1 February 2019Consortium partner in NRO-funded research into selection effects on diversity of medical-student populations, led from Amsterdam UMC (VUmc).
• Universitas Gadjah Mada (UGM, Yogyakarta)coreStrategic or Co-development Partner · 19 December 2018Annual joint delivery of the Global Health Indonesia minor with VUmc; Amsterdam UMC students complete an eight-week preparation, language course and field placement in Yogyakarta health centres and the UGM academic hospital.
• OLVGcoreImplementation/ SI/ Consulting Partner · 6 November 2018Full-accreditation partner in the Regionaal Opleidingsnetwerk Neurologie Amsterdam (RONA) for neurologist training, alongside Amsterdam UMC locaties AMC and VUmc.
• Antoni van Leeuwenhoek HospitalcoreImplementation/ SI/ Consulting Partner · 6 November 2018Contributes subspecialist training capacity to the RONA regional neurology training network led by Amsterdam UMC.
• FlevoziekenhuisminorImplementation/ SI/ Consulting Partner · 6 November 2018Partial-rotation partner in the RONA neurology training network with Amsterdam UMC.
• Spaarne GasthuisminorImplementation/ SI/ Consulting Partner · 6 November 2018Partial-rotation partner in the RONA neurology training network with Amsterdam UMC.
• Noordwest ZiekenhuisgroepminorImplementation/ SI/ Consulting Partner · 6 November 2018Partial-rotation partner in the RONA neurology training network with Amsterdam UMC.
• St Antonius Ziekenhuis (Nieuwegein)minorImplementation/ SI/ Consulting Partner · 6 November 2018Contributes to the new RONA neurology training programme with Amsterdam UMC.
• SEIN (Heemstede)minorImplementation/ SI/ Consulting Partner · 6 November 2018Contributes to the new RONA neurology training programme with Amsterdam UMC.
• Vrije Universiteit (VU Amsterdam)flagshipStrategic or Co-development PartnerHost university of the Faculty of Medicine VU and BKO intensive for professors, integrated with Amsterdam UMC's clinical and research activities; co-develops the first Dutch geneeskunde opleiding without a cum laude regulation in the master phase.
• University of Amsterdam (UvA)flagshipStrategic or Co-development PartnerHost of the UvA Faculty of Medicine at Amsterdam UMC, offering bachelor and (post-initial) master programmes in Medicine, Medical Informatics and Epidemiology with a strong research culture.
• Apple (Apple Watch)coreTechnology or IntegrationAmsterdam UMC researchers used Apple Watch PPG/ECG capabilities in the 437-patient JACC-published atrial fibrillation detection study; cardiologist Michael Winter publicly argued for health services to provide the device free of charge.
• Vrije Universiteit (VU) Faculty of MedicineflagshipStrategic or Co-development PartnerFaculty of Medicine VU trains doctors and top researchers; offers the first Dutch geneeskunde opleiding without a cum laude regulation in the master phase.
• VU minor Global Health Indonesia programmeminorStrategic or Co-development PartnerAnnual joint minor offered by VUmc and UGM in Yogyakarta, including Bahasa Indonesia language training and village health-centre placements.

Scale indicators13 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Maastricht UMC+: Southernmost Dutch UMC providing the same integrated academic medical center model. Comparable in scale and complexity and competes in national expertise-center rankings and NWO/Horizon Europe grant capture.
• Radboudumc: Nijmegen-based Dutch university medical center with comparable patient care, research, and education functions and similar grant-funded research portfolio. Competes directly for NWO grants, medical specialists, and tertiary referrals.
• Erasmus MC: Rotterdam-based Dutch university medical center with comparable integrated patient care, biomedical research, and medical education portfolio. Direct competitor for talent, NWO/NRO grants, and tertiary referrals across the Randstad, and confirmed consortium partner with Amsterdam UMC on NRO-funded medical-education diversity research.
• UMC Utrecht: One of the seven Dutch UMCs and a direct competitor for research funding, expertise-center status, and tertiary referrals. Operates a comparable combined clinical-research-education model and is a relevant benchmark for academic medical center scale and digital patient services.
• University Medical Center Groningen (UMCG): Northern Netherlands UMC and one of the seven Dutch academic medical centers. Comparable in scope of expertise centers, research output, and educational programs; competes for national tertiary referrals and EU consortium leadership.
• Leiden University Medical Center (LUMC): Dutch UMC partner in the PARADISE consortium (NWO Open Technology MRI ex vivo heart grant). Directly comparable as an academic hospital combining tertiary care, biomedical research, and medical training in the Randstad region.

Emerging players

• King's College London: Co-leads the ACCESS-AD pan-European Alzheimer's consortium with Amsterdam UMC, Siemens Healthineers, and Gates Ventures. Comparable as a translational clinical-research partner for disease-modifying therapy implementation across European health systems.

Broad incumbents

• Charité – Universitätsmedizin Berlin: One of Europe's largest university medical centers with integrated care, research, and education across multiple campuses. Comparable in two-campus integration scale and translational research depth, including EU consortium participation.

Others

• Eindhoven University of Technology: Strategic co-development partner with Amsterdam UMC and Cosmo Pharmaceuticals on the AI-based Barrett's esophagus CADe system. Adjacent as an enabling engineering/AI research partner rather than a clinical competitor, but a meaningful collaboration node for translational AI work.

Regional players

• Karolinska University Hospital: Swedish university hospital and academic medical center with comparable tertiary care, biomedical research, and medical training mission. Comparable structural peer for benchmarking European UMC operating models outside the Netherlands.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/amsterdamumc
• YouTubeyoutube.com/user/AmsterdamVUmc/featured
• Facebookfacebook.com/amsterdamumc.nl
• LinkedInlinkedin.com/company/amsterdamumc
• Instagraminstagram.com/amsterdamumc

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amsterdam UMC